These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24283962)

  • 1. PET radiotracers for molecular imaging in dementia.
    Baskin A; Giannakopoulos P; Ratib O; Seimbille Y; Assal F; Perani D; Garibotto V
    Curr Radiopharm; 2013 Dec; 6(4):215-30. PubMed ID: 24283962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.
    Xia C; Dickerson BC
    PET Clin; 2017 Jul; 12(3):351-359. PubMed ID: 28576172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current and future prospects of nuclear medicine in dementia].
    Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
    Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular imaging of Alzheimer's disease].
    Albert A; Borbély K
    Orv Hetil; 2019 Aug; 160(33):1289-1295. PubMed ID: 31401858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions.
    Rowley PA; Samsonov AA; Betthauser TJ; Pirasteh A; Johnson SC; Eisenmenger LB
    Semin Ultrasound CT MR; 2020 Dec; 41(6):572-583. PubMed ID: 33308496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.
    Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report.
    Schroeter ML; Tiepolt S; Marschhauser A; Thöne-Otto A; Hoffmann KT; Barthel H; Obrig H; Sabri O
    BMC Neurol; 2015 Aug; 15():152. PubMed ID: 26303364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting molecular mechanisms in the living brain of dementia patients.
    Barrio JR; Satyamurthy N; Huang SC; Petric A; Small GW; Kepe V
    Acc Chem Res; 2009 Jul; 42(7):842-50. PubMed ID: 19281227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers.
    Bao W; Jia H; Finnema S; Cai Z; Carson RE; Huang YH
    PET Clin; 2017 Jul; 12(3):329-350. PubMed ID: 28576171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
    Smith R; Wibom M; Olsson T; Hägerström D; Jögi J; Rabinovici GD; Hansson O
    J Alzheimers Dis; 2016; 51(2):339-43. PubMed ID: 26836192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET and amyloid-PET imaging: the diverging paths.
    Perani D
    Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT of Dementia.
    Zukotynski K; Kuo PH; Mikulis D; Rosa-Neto P; Strafella AP; Subramaniam RM; Black SE
    AJR Am J Roentgenol; 2018 Aug; 211(2):246-259. PubMed ID: 29949415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
    Wang T; Huang Q; Reiman EM; Chen K; Li X; Li G; Lin Z; Li C; Xiao S
    J Clin Psychopharmacol; 2013 Oct; 33(5):636-42. PubMed ID: 23948786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.